VILLEJUIF, France--(BUSINESS WIRE)--Registration for the second annual WIN Symposium on personalized cancer medicine is still open, with a preferential rate available until the 4^th of July. This unique event, to be held on the 7^th to 9^th of July 2010 in the Palais des Congrès, Paris, will offer an unprecedented opportunity to discuss the latest advances in tailored cancer medicine, focusing on early diagnosis and rapid translation of scientific discoveries to clinical practice.

Supported by media partner Nature Publishing Group and technology founders Agilent Technologies, GE Healthcare and Life Technologies, the WIN Symposium aims to develop greater collaboration in the scientific community, both academic and industrial. The WIN Symposium’s innovative approach has been endorsed by numerous academic institutions and oncology organizations around the world – including the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO) and the Organisation of European Cancer Institutes (OECI) – as well as sponsorship from the National Breast Cancer Foundation, Inc. and sanofi-aventis.

The program of the WIN Symposium will be dedicated to early diagnosis, personalized medicine and the future of oncology care, and will give participants the chance to discuss this complex issue with key opinion leaders, in an open and interactive forum. The WIN Symposium has been accredited with 17 ESMO-MORA category 1 points.

Register now to attend this unique event.

About the WIN Consortium

The WIN Consortium is a joint initiative of the Institut Gustave Roussy and The University of Texas M. D. Anderson Cancer Center, in association with several other leading cancer care institutions in Europe, the United States of America, Canada, and Asia. The Consortium aims at building new strategic alliances in oncology, creating innovative drug development programs and at accelerating clinical trials and validation of new drugs for personalized cancer care. Its SITED program (standards in individualized treatment and early diagnosis) will bring together academia and industry, undertaking a range of research and clinical projects to improve early diagnosis of cancer and to establish new treatment strategies. Follow WIN Consortium on Twitter @WIN_Consortium and on Facebook.